Patent Grant
10815345
The present invention relates to a method for preparing a matrix of chitosan including a fiber reinforcement member sandwiched between two porous layers of chitosan. The present invention further relates to matrices obtained by this method and their use as, or in the manufacture of, wall reinforcement implant that may be used, for example, in the repair, reinforcement or replacement of soft tissues, e.g. treatment of hernias, reconstruction of a wall, such as a visceral or abdominal wall. The implants of the invention may also be used in vitro as a tissue engineering product or support for culturing live cells.
Chitosan is a polysaccharide which results from the deacetylation of chitin. Chitin is one of the most widespread natural polysaccharides on earth and is extracted from the exoskeletons of arthropods, from the endoskeletons of cephalopods and also from fungi.
Chitosan has properties, such as biodegradability, bioresorbability, biocompatibility, non-toxicity and mechanical properties, which make it particularly advantageous for medical applications. Thus, chitosan can be incorporated into medical devices as a constituent of implants, for example in the form of a porous structure such as a matrix. Chitosan in fact offers a good compromise, given the desired properties, for an abdominal wall reinforcement implant, namely good biological compatibility and good mechanical properties.
Chitosan matrices are usually obtained by lyophilization of a chitosan solution. Lyophilization involves a first step during which a solution is frozen in a particular structure, and then a second step, during which a controlled pressure is applied in order to cause sublimation of the water present in the frozen structure. At the end of the sublimation step, only the constituents present in the initial solution remain, thus producing a porous structure.
Indeed, the porous structure of such chitosan matrices is of particular interest in the manufacture of surgical implants for many reasons. When the implant is intended to repair a tissue defect, for example in the case of a hernia in the abdominal wall, a porous structure favors cell colonization and therefore reconstruction of the biological tissue.
Wall reinforcement implants, for example for reinforcing the abdominal wall, are widely used in surgery. These implants are intended to treat hernias by temporarily or permanently filling a tissue defect. These implants may show a number of shapes, for example rectangular, circular or oval, depending on the anatomical structure to which they are to adapt. These implants may be made entirely from bioresorbable elements when they are intended to disappear after they have performed their reinforcing function during the period of cellular colonization and tissue rehabilitation. Alternatively, these implants may include, or consist in, non-bioresorbable parts which are intended to remain permanently in the body of the patient.
In addition to exhibit a porosity favourable to cell growth, the structure of an abdominal wall reinforcement implant should at the same time possess mechanical properties allowing it to be easily handleable by the surgeon, to perform its reinforcement function once implanted and to maintain its integrity at least during the time necessary for reconstruction, even when submitted to potential tensions, generated for example either by sutures ensuring the fixation of the implant to the surrounding biological tissue or by the various movements of the patient in his daily life.
Depending on the level of mechanical properties desired for a wall reinforcement implant, it may be useful to reinforce a chitosan matrix obtained by lyophilization of a chitosan solution by combining it with a fiber reinforcement member, such as a mesh.
It is known to lyophilize a chitosan solution in which a fiber reinforcement member such as a mesh is previously immersed in order to obtain a mesh embedded in a chitosan matrix. Anyway, after lyophilization, the chitosan matrices are still very loaded with salts. The matrices must therefore be neutralized before being used as an implant.
It has been observed that the shrinkage of matrices that usually go along with the neutralization of these matrices induces high constraints in the embedded mesh. This phenomenon is detrimental to the use of the resulting matrix as an implant, as the mesh will not behave as expected after implantation.
It would therefore be desirable to implement a method of preparing chitosan matrices having a fiber reinforcement member embedded therein, where the fiber reinforcement member would not be damaged or affected by the preparation method and where the integrity of the matrix would be preserved.
The present invention relates to a method for preparing a chitosan-based matrix comprising a fiber reinforcement member embedded in said matrix comprising the following steps:
The method according to the invention makes it possible to obtain chitosan-based matrix including a fiber reinforcement member embedded in the matrix, where the matrix shows a good integrity and good mechanical properties. In particular, the fiber reinforcement member of the matrices of the invention is neither damaged nor affected by the preparation method of the matrix. The fiber reinforcement member of the matrices of the invention is not submitted to constraints tending to deform it in either direction. No shrinkage of the fiber reinforcement member is observed in the matrices of the invention.
In particular, the matrices obtained by the method of the invention show a good stability and a good cohesion of the various parts constituting the matrix, namely the two chitosan porous layers and the fiber reinforcement member. In the matrices obtained by the method of the invention, no delamination between the chitosan porous layers and the fiber reinforcement member is observed when immersed in water even after a long exposure time. In the matrices obtained by the method of the invention, the fiber reinforcement member is securely sandwiched between the two porous layers of chitosan.
The chitosan matrices obtained by means of the method according to the invention therefore make it possible to obtain particularly effective surgical implants, for example for reinforcing the abdominal wall. The chitosan matrices obtained by the method of the invention may be used on their own or in combination with another element, such as for example a film, an additional reinforcement member or an additional porous layer.
The invention and the advantages thereof will emerge more clearly from the detailed description below and the appended figures in which:
By “chitosan-based matrix” it is intended to mean according to the present application that the major compound of the solution(s) from which the porous layers forming the matrix of the invention are obtained by lyophilisation is chitosan. In embodiments, the solution(s) from which the chitosan porous layers are obtained is/are substantially free of any other polymer. In the present application, by “substantially free of any other polymer” is meant that the solution(s) contain less than 5%, preferably less than 1% in weight of other polymer. In embodiments, the chitosan solution(s) used in the method of the invention is/are free of any other polymer.
According to a first step of the method according to the invention, step a), two separate chitosan porous layers obtained from lyophilisation of layers of one or more solution(s) of chitosan are provided. The two chitosan porous layers may be identical or different in composition. For example, the compositions of the two chitosan porous layers may be different with respect to the concentration of chitosan, and/or to the degree of acetylation of the chitosan used, and/or to the origin of the chitosan used, etc. . . . . When it is intended to use two chitosan porous layers having different compositions in the method of the invention, two different chitosan solutions are prepared and each porous layer is obtained from lyophilisation of a layer of the corresponding chitosan solution. Alternatively, when it is intended to use two chitosan porous layers having identical compositions, a single chitosan solution may be prepared. In such a case, the two chitosan porous layers may be obtained either by lyophilisation of two separate layers of the single chitosan solution, or by cutting in two one thicker porous layer obtained by lyophilisation of one appropriate layer of the single chitosan solution.
Chitosan is a biocompatible biopolymer resulting from the deacetylation of chitin. Chitin is extracted from exoskeletons of arthropods such as lobster, crab or shrimp, from the endoskeleton of cephalopods such as squid, or else from fungi. The extraction of chitin involves steps of protein and lipid hydrolysis, of depigmentation and of demineralization. Usually, the protein and lipid hydrolysis is carried out in the presence of sodium hydroxide, the demineralization requiring the use of hydrochloric acid.
Once the chitin has been extracted, the chitosan is obtained by means of a deacetylation step, which consists of hydrolysis of the acetamide groups. This reaction is generally carried out at high temperature in an alkaline solution, for example a solution of sodium hydroxide (NaOH) at 48% in water, at 90° C.
The following publications also describe methods for deacetylation of chitin in order to obtain chitosan: “Lamarque, G., C. Viton, and A. Domard, New Route of Deacetylation of α-and β-Chitins by Means of Freeze-Pump Out-Thaw Cycles. Biomacromolecules, 2005. 6(3): p. 1380-1388.”, “Lamarque, G., C. Viton, and A. Domard, Comparative Study of the First Heterogeneous Deacetylation of α-and β-Chitins in a Multistep Process. Biomacromolecules, 2004. 5(3): p. 992-1001.”, “Lamarque, G., C. Viton, and A. Domard, Comparative Study of the Second and Third Heterogeneous Deacetylations of α-and β-Chitins in a Multistep Process. Biomacromolecules, 2004. 5(5): p. 1899-1907.”, “Tolaimate, A., et al., Contribution to the preparation of chitins and chitosans with controlled physico-chemical properties. Polymer, 2003. 44(26): p. 7939-7952.”
Chitosans which are suitable as starting materials for the method according to the invention are available from the companies Kitozyme (fungus extract), Heppe Medical chitosan (shrimp or crab extract), Primex (shrimp extract) and Novamatrix (shrimp extract).
Chitosan is a biodegradable compound. The degree of acetylation of chitosan can have an influence on the chitosan degradation kinetics. Thus, depending on the biodegradation kinetics desired for the each chitosan porous layer of the matrix prepared according to the method of the invention, the chitosan used in each porous layer may have a degree of acetylation of 2, 3, 10, 20, 30, 40 or else 50%: the desired degree of acetylation can also be obtained by preparing a mixture of several chitosans having various degrees of acetylation. In particular, the degree of acetylation of the chitosan used for one chitosan porous layer may be different from the degree of acetylation of the chitosan used for the other chitosan porous layer.
The chitosan solutions of step a) of the method according to the invention are generally prepared by solubilization of chitosan in powder form in water. The solutions may be adjusted to the desired pH, for example by adding acetic acid. In embodiments of the method according to the invention, the pH of each chitosan solution is adjusted to a value ranging from 3 to 5, preferably to 3.5, for example by adding acetic acid. Such a pH makes it possible to obtain, in the end, a chitosan-based porous matrix which has good mechanical properties.
In embodiments of the method according to the invention, each solution of step a) is a solution of chitosan in water, the chitosan concentration in said solution ranging from 0.1% to 10%, preferably from 0.5% to 3% and more preferably from 0.8% to 1% by weight, relative to the total weight of the solution.
Such chitosan concentrations make it possible to obtain, in the end, chitosan porous layers/matrices having good mechanical properties. Also preferably, each chitosan solution of the method according to the invention is free of any other polymer. The presence of a polymer other than chitosan in the solution could affect the mechanical or biological properties of the matrices.
Two separate chitosan porous layers are prepared from the lyophilisation of layer(s) of the chitosan solution(s) prepared as described above. When the two separate chitosan porous layers to be used in the method of the invention are of different compositions, two different chitosan solutions are prepared. A part of each solution is poured in a mould in order to form a solution layer. Each mould is in general in the shape of a rectangle having dimensions compatible with the chitosan porous layer to be prepared. Each chitosan porous layer is obtained from lyophilisation of the corresponding solution layer. When it is intended to use two chitosan porous layers of identical compositions, parts of the single chitosan solution may be poured into two moulds in order to form two solution layers. The two separate chitosan porous layers will be obtained from lyophilisation of the two solution layers. Alternatively, a larger volume of the single chitosan solution may be poured in a bigger mould in order to form a thicker solution layer. The two separate chitosan porous layers intended to be used in the method of the invention are then obtained by cutting the thicker porous layer obtained by lyophilisation of the thicker solution layer into two thinner chitosan porous layers.
In the present application, the term “porous layer” is intended to mean a layer which has pores, or gaps, alveoli, holes, orifices, which are evenly or unevenly distributed not only at the surface, but also within the thickness of said layer, and which are more or less interconnected, depending on the lyophilization process used. Such lyophilization processes are known. It is known practice to vary the freezing temperature and speed and also the characteristics of the polymer solution to be lyophilized (pH, concentration, etc.), in this case chitosan, as a function of the structure of the sponge or porous layer that it is desired to obtain (see U.S. Pat. No. 4,970,298; Doillon et al, J Biomed Mater Res, 1986; Schoof, J Biomed Mater Res, 2001; O'Brien et al, Biomaterials, 2004).
According to a second step of the method according to the invention, step b), the chitosan porous layers of step a) are neutralized and washed.
The chitosan porous layers may for example be neutralized by immersion in a neutralizing solution. The neutralizing solution may be a basic solution, such as a NaOH or NH4OH solution in water or in an alcohol such as ethanol. For example, each chitosan porous layer may be dipped during five minutes in about 600-800 mL of neutralizing solution, such as a solution of NaOH 0.5M in pure ethanol.
The neutralized chitosan porous layers are then submitted to one or more washing steps. The washing step makes it possible to eliminate from a chitosan porous layer any salts still remaining in the layer, for instance sodium acetate or ammonium acetate salts.
For example, each neutralized chitosan porous layer is dipped in one or more baths of sterile water until a washing water with a pH close to 7 is obtained.
According to a third step of the method according to the invention, step c), a face of each chitosan porous layer obtained in b) is acidified with an acid. For example, a superficial layer of each chitosan porous layer is acidified with a fine layer of acid. The acidification of the face is preferably limited to a superficial layer of the chitosan porous layer so as not to degrade the chitosan porous layer. The acid is preferably spread out on the face of the chitosan porous layer in a quantity so as to cause a gentle and slight resolubilization of a superficial layer of said face. For example, the thickness of the superficial layer which is acidified may represent up to 5%, preferably up to 2% of the total thickness of the chitosan porous layer.
In embodiments, the face is acidified by spraying a solution of said acid on said face. The spraying may be repeated twice.
In embodiments, the acid is selected from acetic acid, hydrochloric acid, citric acid, sulphuric acid, lactic acid, and mixtures thereof. In embodiments, the acid is acetic acid.
In embodiments, the face is acidified by spraying a solution of acetic acid at 0.1 M on said face, for example twice.
In a fourth step of the method according to the invention, step d), a fiber reinforcement member is provided.
Some suitable non-limiting examples of the fiber reinforcement member include fabrics, meshes, monofilaments, multifilament braids, chopped fibers (sometimes referred to in the art as staple fibers) and combinations thereof.
In embodiments, the fiber reinforcement member is a porous mesh. The fiber reinforcement member may be prepared using any technique known to those skilled in the art, such as knitting, weaving, tatting, knipling or the like. Illustrative examples of suitable meshes include any of those that are presently commercially available for abdominal wall repair. In embodiments where a mesh is used as the fiber reinforcement member, the mesh will bring mechanical properties to the matrix or implant and will aid in affixing the matrix or implant comprising the matrix to the surrounding biological tissue.
Where monofilaments or multifilament braids are used as the reinforcement member, the monofilaments or multifilament braids may be oriented in any desired manner. Where chopped fibers are used as the reinforcement member, the chopped fibers may be oriented in any desired manner. For example, the chopped fibers may be randomly oriented or may be oriented in a common direction. The chopped fibers can thus form a non-woven material, such as a mat or a felt.
The fiber reinforcement member may be made from any biocompatible polymer material. The biocompatible polymer may be synthetic or natural. The biocompatible polymer may be biodegradable, non-biodegradable or a combination of biodegradable and non-biodegradable. The term “biodegradable” as used herein is defined to include both bioabsorbable and bioresorbable materials. By biodegradable, it is meant that the materials decompose, or lose structural integrity under body conditions (e.g., enzymatic degradation or hydrolysis) or are broken down (physically or chemically) under physiologic conditions in the body such that the degradation products are excretable or absorbable by the body.
The biocompatible polymer may be selected from the group consisting of biodegradable polymers, non-biodegradable polymers, and combinations thereof.
In embodiments, the reinforcement member may include at least a non-bioabsorbable material to provide long term tissue support. In other embodiments, the reinforcement member is formed entirely of bioabsorbable material, for example when the implant of the invention is not intended to be a long lasting tissue support.
In embodiments, the biocompatible polymer material is selected from polypropylene (PP), polyester such as polyethylene terephthalates (PET), polyamide, silicone, polyether ether ketone (PEEK), polyarylether ether ketone (PAEK) polylactic acid (PLA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoate (PHA), polyglycolic acid (PGA), copolymers of these materials, and mixtures thereof.
In embodiments, the biocompatible polymer material is selected from polypropylene, polyethylene terephthalates and mixtures thereof.
The fiber reinforcement member is positioned between the two acidified faces of the chitosan porous layers. Wth reference to
The fiber reinforcement 3 is therefore sandwiched between the two chitosan porous layers (1, 2), and imprisoned in the two acidified superficial layers (1a, 2a) which melt together, as shown on
In embodiments, the pressure applied may range from about 2.5 to about 10 kPa, preferably is about 3.5 kPa.
In a fifth step of the method of the invention, step e), the fiber reinforcement member and the two chitosan porous layers are let to dry.
The drying may take place under a hood for example, for a time ranging from about 8 hours to about 12 hours for instance.
During the drying step, the resolubilized superficial layers (1a, 2a) of the chitosan porous layers which surround the fiber reinforcement member 3 solidify. The fiber reinforcement member 3 eventually strongly adheres to the faces of the chitosan porous layers (1, 2). At the end of the drying step, the two chitosan porous layers (1, 2) and the fiber reinforcement member 3 are securely bound together, as shown on
The matrix obtained 4 is under the form of a fiber reinforcement member 3 sandwiched between two porous layers (1, 2) of chitosan, as shown on
In embodiments, in step d) above, the fiber reinforcement member is impregnated with a solution of acid before being positioned between the two acidified faces of the two chitosan porous layers. In embodiments, the solution of acid may be a solution of an acid selected from acetic acid, hydrochloric acid, citric acid, sulphuric acid, lactic acid, and mixtures thereof, and preferably a solution of acetic acid.
In embodiments, the fiber reinforcement member is impregnated with a solution of acetic acid. For example, the fiber reinforcement member is dipped into a solution of acetic acid at 0.1 M. Such embodiments allow obtaining an excellent and homogeneous bonding between the fiber reinforcement member and the two chitosan porous layers.
In embodiments, the chitosan porous layers and the fiber reinforcement member having substantially bidimensional structures, the area of the fiber reinforcement member is smaller than that of each chitosan porous layers. Such embodiments show a very good resistance to natural delamination as well as to provoked delamination.
By “substantially bidimensional structure” is meant in the present application that the structure has one of its three dimensions which is significantly smaller than the two others so that the structure is substantially planar, such as a layer having a small thickness, or a mesh.
For example, the chitosan porous layers may have the same dimensions and may be under the form of rectangular layers having a length L and a width W, and a thickness much smaller than L and W. The fiber reinforcement member may be under the shape of a bidimensional textile having a length LF and a width WF. In embodiments, the area LF×WF of the fiber reinforcement member is smaller than the area L×W of each chitosan porous layers.
The matrix obtained by the method of the invention can be part of or constitute the whole of a surgical implant, for example for reinforcing the abdominal wall.
Thus, another aspect of the invention relates to a chitosan-based matrix obtained by the method described above.
Another aspect of the invention relates to an implant, in particular for reinforcing the abdominal wall, comprising at least one matrix obtained by means of the method described above.
The invention and the advantages thereof will emerge more clearly from the examples below.
1°) Production of Two Separate Chitosan Porous Layers:
Porous layers of chitosan of DA (degree of acetylation) 4% were produced according to the following procedure.
A 1% (w/w) chitosan solution is prepared as follows: 4.70 g of chitosan were first suspended in 445 g sterile water and dissolved under mechanical stirring by adding 1.56 ml of acetic acid to achieve the stoechiometric protonation of free amine groups of D-glucosamine residues. Usually, an excess of 10% of acetic acid is added to enhance the dissolution.
This operation is realized in a STEPHAN unit with mechanical stirring at 300 rpm and room temperature. To avoid any temperature increase, the bowl is equipped with a cooling bath to maintain the room temperature at a temperature T<25° C. The dissolution takes about 2 to 3 hours in these conditions.
After complete dissolution of the polymer, the pH of the chitosan solution is 4.5. The pH is then adjusted to pH 3.5 by addition of 7.5 ml of acetic acid. Solutions of pH 3.5 allow improving the mechanical properties of the resulting chitosan porous layer. The 1% (w/w) chitosan solution is then degassed under static vacuum: such a step allows removing air bubbles that could impact both porosity and mechanical properties of the resulting matrices. For example, the solution is degassed at 150 mbars, 300 rpm and 25° C. for 30 min. 2 or 3 degassing cycles are usually necessary to achieve complete degassing.
121 g of degassed chitosan solution are then poured in a plastic mould of 12 cm×17 cm dimensions in order to form a layer which is freeze-dried in a TELSTAR Lyobeta freeze drier according to a 28 hours cycle, namely a freezing step of about 4 hours and a primary drying step of about 24 hours.
A first chitosan porous layer is obtained. The same procedure is repeated in order to obtain a second chitosan porous layer.
In the present example, the two chitosan porous layers have identical compositions. In other embodiments, the composition of one chitosan porous layer could be different from that of the other chitosan porous layer, in particular regarding the concentration of chitosan and/or the degree of acetylation of chitosan, and/or the origin of the chitosan, etc. . . . .
2°) Neutralization of the Chitosan Porous Layers Produced at 1°):
The chitosan porous layers obtained at point 1°) above were neutralized by immersion during 10 minutes into a neutralizing solution of NaOH 0.5M in 96% ethanol. The chitosan porous layers were then washed in sterile water baths during 10 min (typically 1 L/matrix) to remove the excess of sodium hydroxide and residual salts. Washings were repeated until the washing solution reached a neutral pH and a conductivity below 2 μS/cm.
After neutralization, the chitosan porous layers show dimensions of 10 cm×15 cm and were further recut at the following dimensions: 6 cm×4 cm. They have a thickness ranging from about 4 mm to about 5 mm.)
3°) Assembling of a Matrix of the Invention:
A fiber reinforcement member under the form of a knit made of polyethylene terephthalate and having dimensions of 6 cm×4 cm is provided.
A face of each chitosan porous layer obtained at point 2°) above is acidified by spraying thereon a fine layer of a solution of acetic acid at a concentration of 0.1 M. The spraying is repeated twice in a homogeneous way. Only a superficial layer of the face is acidified so that the integrity of the chitosan porous layer is preserved. This acidification of the face has as a consequence to resolubilize a superficial layer of said chitosan porous layer. The thickness of the acidified superficial layer represents about 1% of the total thickness of the chitosan porous layer.
The fiber reinforcement member is positioned between the two chitosan porous layers with the acidified faces of the chitosan porous layers directed towards the fiber reinforcement member.
A pressure of about 3.5 kPa is applied on the two chitosan porous layers towards the fiber reinforcement member, by depositing on the chitosan porous layers a mass of 850 g during about 20 seconds.
The mass is then removed and the matrix, made of the fiber reinforcement member sandwiched between the two chitosan porous layers, is let to dry under a hood for about 8-12 hours at room temperature (about 20° C.).
During the drying step, the resolubilized superficial layers of the chitosan porous layers which surround the fiber reinforcement member solidify and eventually imprison the fiber reinforcement member which strongly adheres to the faces of the chitosan porous layers. At the end of the drying step, the two chitosan porous layers and the fiber reinforcement member are securely bound together.
Once the matrix is dried, it is very stable and no delamination of the fiber reinforcement member from the two chitosan porous layers occurs.
The matrix is put in a water bath for 1 hour. No delamination of the fiber reinforcement member from the two chitosan porous layers is observed.
A matrix of the invention is prepared in the same manner as in EXAMPLE 1 above, except that the fiber reinforcement member is dipped into a solution of acetic acid at a concentration of 0.1 M prior to be positioned between the two acidified faces of the chitosan porous layers.
The matrix is dried in the same manner as in EXAMPLE 1.
The matrix obtained is very stable and no delamination of the fiber reinforcement member from the two chitosan porous layers occurs.
The matrix is put in a water bath for 1 hour. No delamination of the fiber reinforcement member from the two chitosan porous layers is observed. In addition, if one attempts to delaminate the two chitosan porous layers of the matrix by pulling out in opposite directions the end of each chitosan porous layer, a significant resistance to said delamination is observed: in particular, if two jaws of a holder grasp the opposite chitosan porous layers of the matrix and are then taken away one from the other, the matrix breaks at the place it is grasped by one of the jaws but no delamination is observed between the fiber reinforcement member and the chitosan porous layers.
A matrix of the invention is prepared in the same manner as in EXAMPLE 1 above, except that the fiber reinforcement member has the following dimensions: 4 cm×4 cm.
The matrix obtained is very stable and no delamination of the fiber reinforcement member from the two chitosan porous layers occurs.
The matrix is put in a water bath for 1 hour. No delamination of the fiber reinforcement member from the two chitosan porous layers is observed.
A matrix of the invention is prepared in the same manner as in EXAMPLE 2 above, except that the fiber reinforcement member has the following dimensions: 4 cm×4 cm.
The matrix obtained is very stable and no delamination of the fiber reinforcement member from the two chitosan porous layers occurs.
The matrix is put in a water bath for 1 hour. No delamination of the fiber reinforcement member from the two chitosan porous layers is observed.
In addition, if one attempts to delaminate the two chitosan porous layers of the matrix by pulling out in opposite directions the end of each chitosan porous layer, a significant resistance to delamination and to tearing is observed. In particular, in such conditions, a greater resistance to delamination and to tearing is observed with the matrix of the present example compared to the matrices of Examples 1-3.
Matrices of the invention prepared in the four examples above may be used on their own as wall reinforcement implants to be implanted in a patient for hernia repair for example. Alternatively, these matrices may be used in combination with a anti-adhesion barrier film or with one or more additional matrices/porous layers in order to manufacture a composite surgical implant.
| Number | Date | Country | Kind |
|---|---|---|---|
| 15305236 | Feb 2015 | EP | regional |
This application is a divisional of U.S. patent application Ser. No. 15/003,975 filed Jan. 22, 2016, which claims benefit of and priority to European Patent Application Serial No. 15305236.0 filed Feb. 17, 2015, the disclosure of the above-identified application is hereby incorporated by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 1187158 | Mcginley | Jun 1916 | A |
| 3054406 | Usher | Sep 1962 | A |
| 3118294 | Van Laethem | Jan 1964 | A |
| 3124136 | Usher | Mar 1964 | A |
| 3272204 | Artandi et al. | Sep 1966 | A |
| 3276448 | Kronenthal | Oct 1966 | A |
| 3320649 | Naimer | May 1967 | A |
| 3364200 | Ashton et al. | Jan 1968 | A |
| 3570482 | Shigeru et al. | Mar 1971 | A |
| 3718725 | Hamano | Feb 1973 | A |
| 4006747 | Kronenthal et al. | Feb 1977 | A |
| 4060081 | Yannas et al. | Nov 1977 | A |
| 4173131 | Melton et al. | Nov 1979 | A |
| 4193137 | Heck | Mar 1980 | A |
| 4248064 | Odham | Feb 1981 | A |
| 4294241 | Miyata | Oct 1981 | A |
| 4307717 | Hymes et al. | Dec 1981 | A |
| 4338800 | Matsuda | Jul 1982 | A |
| 4476697 | Schafer et al. | Oct 1984 | A |
| 4487865 | Balazs et al. | Dec 1984 | A |
| 4500676 | Balazs et al. | Feb 1985 | A |
| 4511653 | Play et al. | Apr 1985 | A |
| 4527404 | Nakagaki et al. | Jul 1985 | A |
| 4591501 | Cioca | May 1986 | A |
| 4597762 | Walter et al. | Jul 1986 | A |
| 4603695 | Ikada et al. | Aug 1986 | A |
| 4631932 | Sommers | Dec 1986 | A |
| 4670014 | Huc et al. | Jun 1987 | A |
| 4709562 | Matsuda | Dec 1987 | A |
| 4748078 | Doi et al. | May 1988 | A |
| 4759354 | Quarfoot | Jul 1988 | A |
| 4769038 | Bendavid et al. | Sep 1988 | A |
| 4796603 | Dahlke et al. | Jan 1989 | A |
| 4813942 | Alvarez | Mar 1989 | A |
| 4841962 | Berg et al. | Jun 1989 | A |
| 4854316 | Davis | Aug 1989 | A |
| 4925294 | Geshwind et al. | May 1990 | A |
| 4931546 | Tardy et al. | Jun 1990 | A |
| 4942875 | Hlavacek et al. | Jul 1990 | A |
| 4948540 | Nigam | Aug 1990 | A |
| 4950483 | Ksander et al. | Aug 1990 | A |
| 4970298 | Silver et al. | Nov 1990 | A |
| 4976737 | Leake | Dec 1990 | A |
| 5002551 | Linsky et al. | Mar 1991 | A |
| 5015584 | Brysk | May 1991 | A |
| 5116357 | Eberbach | May 1992 | A |
| 5147374 | Fernandez | Sep 1992 | A |
| 5162430 | Rhee et al. | Nov 1992 | A |
| 5171273 | Silver et al. | Dec 1992 | A |
| 5176692 | Wilk et al. | Jan 1993 | A |
| 5192301 | Kamiya et al. | Mar 1993 | A |
| 5195542 | Gazielly et al. | Mar 1993 | A |
| 5196185 | Silver et al. | Mar 1993 | A |
| 5201745 | Tayot et al. | Apr 1993 | A |
| 5201764 | Kelman et al. | Apr 1993 | A |
| 5206028 | Li | Apr 1993 | A |
| 5217493 | Raad et al. | Jun 1993 | A |
| 5254133 | Seid | Oct 1993 | A |
| 5256418 | Kemp et al. | Oct 1993 | A |
| 5258000 | Gianturco | Nov 1993 | A |
| 5263983 | Yoshizato et al. | Nov 1993 | A |
| 5304595 | Rhee et al. | Apr 1994 | A |
| 5306500 | Rhee et al. | Apr 1994 | A |
| 5324775 | Rhee et al. | Jun 1994 | A |
| 5328955 | Rhee et al. | Jul 1994 | A |
| 5334527 | Brysk | Aug 1994 | A |
| 5339657 | Mcmurray | Aug 1994 | A |
| 5350583 | Yoshizato et al. | Sep 1994 | A |
| 5356432 | Rutkow et al. | Oct 1994 | A |
| 5368549 | Mcvicker | Nov 1994 | A |
| 5368602 | Torre | Nov 1994 | A |
| 5370650 | Jonathan et al. | Dec 1994 | A |
| 5376375 | Rhee et al. | Dec 1994 | A |
| 5376376 | Li | Dec 1994 | A |
| 5397331 | Himpens et al. | Mar 1995 | A |
| 5399361 | Song et al. | Mar 1995 | A |
| 5413791 | Rhee et al. | May 1995 | A |
| 5425740 | Hutchinson, Jr. | Jun 1995 | A |
| 5428022 | Palefsky et al. | Jun 1995 | A |
| 5433996 | Kranzler et al. | Jul 1995 | A |
| 5441491 | Verschoor et al. | Aug 1995 | A |
| 5441508 | Gazielly et al. | Aug 1995 | A |
| 5456693 | Conston et al. | Oct 1995 | A |
| 5456711 | Hudson | Oct 1995 | A |
| 5466462 | Rosenthal et al. | Nov 1995 | A |
| 5480644 | Freed | Jan 1996 | A |
| 5487895 | Dapper et al. | Jan 1996 | A |
| 5490984 | Freed | Feb 1996 | A |
| 5512291 | Li | Apr 1996 | A |
| 5512301 | Song et al. | Apr 1996 | A |
| 5514181 | Light et al. | May 1996 | A |
| 5522840 | Krajicek | Jun 1996 | A |
| 5523348 | Rhee et al. | Jun 1996 | A |
| 5536656 | Kemp et al. | Jul 1996 | A |
| 5543441 | Rhee et al. | Aug 1996 | A |
| 5565210 | Rosenthal et al. | Oct 1996 | A |
| 5567806 | Abdul-Malak et al. | Oct 1996 | A |
| 5569273 | Titone et al. | Oct 1996 | A |
| RE35399 | Eisenberg | Dec 1996 | E |
| 5593441 | Lichtenstein et al. | Jan 1997 | A |
| 5595621 | Light et al. | Jan 1997 | A |
| 5601571 | Moss | Feb 1997 | A |
| 5607474 | Athanasiou et al. | Mar 1997 | A |
| 5607590 | Shimizu | Mar 1997 | A |
| 5614587 | Rhee et al. | Mar 1997 | A |
| 5618551 | Tardy et al. | Apr 1997 | A |
| 5634931 | Kugel | Jun 1997 | A |
| 5639796 | Lee | Jun 1997 | A |
| 5665391 | Lea | Sep 1997 | A |
| 5667839 | Berg | Sep 1997 | A |
| 5676967 | Williams et al. | Oct 1997 | A |
| 5681568 | Goldin et al. | Oct 1997 | A |
| 5686090 | Schilder et al. | Nov 1997 | A |
| 5686115 | Vournakis et al. | Nov 1997 | A |
| 5690675 | Sawyer et al. | Nov 1997 | A |
| 5695525 | Mulhauser et al. | Dec 1997 | A |
| 5697978 | Sgro | Dec 1997 | A |
| 5700476 | Rosenthal et al. | Dec 1997 | A |
| 5700477 | Rosenthal et al. | Dec 1997 | A |
| 5702416 | Kieturakis et al. | Dec 1997 | A |
| 5709934 | Bell et al. | Jan 1998 | A |
| 5711960 | Shikinami | Jan 1998 | A |
| 5716409 | Debbas | Feb 1998 | A |
| 5720981 | Eisinger | Feb 1998 | A |
| 5732572 | Litton | Mar 1998 | A |
| 5743917 | Saxon | Apr 1998 | A |
| 5749895 | Sawyer et al. | May 1998 | A |
| 5752974 | Rhee et al. | May 1998 | A |
| 5766246 | Mulhauser et al. | Jun 1998 | A |
| 5766631 | Arnold | Jun 1998 | A |
| 5769864 | Kugel | Jun 1998 | A |
| 5771716 | Schlussel | Jun 1998 | A |
| 5785983 | Furlan et al. | Jul 1998 | A |
| 5800541 | Rhee et al. | Sep 1998 | A |
| 5814328 | Gunasekaran | Sep 1998 | A |
| 5833705 | Ken et al. | Nov 1998 | A |
| 5840011 | Landgrebe et al. | Nov 1998 | A |
| 5861034 | Taira et al. | Jan 1999 | A |
| 5863984 | Doillon et al. | Jan 1999 | A |
| 5869080 | Mcgregor et al. | Feb 1999 | A |
| 5871767 | Dionne et al. | Feb 1999 | A |
| 5876444 | Lai | Mar 1999 | A |
| 5891558 | Bell et al. | Apr 1999 | A |
| 5899909 | Claren et al. | May 1999 | A |
| 5906937 | Sugiyama et al. | May 1999 | A |
| 5910149 | Kuzmak | Jun 1999 | A |
| 5911731 | Pham et al. | Jun 1999 | A |
| 5916225 | Kugel | Jun 1999 | A |
| 5919232 | Chaffringeon et al. | Jul 1999 | A |
| 5919233 | Knopf et al. | Jul 1999 | A |
| 5919574 | Hoagland | Jul 1999 | A |
| 5922026 | Chin | Jul 1999 | A |
| 5931165 | Reich et al. | Aug 1999 | A |
| 5942278 | Hagedorn et al. | Aug 1999 | A |
| 5962136 | Dewez et al. | Oct 1999 | A |
| 5972022 | Huxel | Oct 1999 | A |
| RE36370 | Li | Nov 1999 | E |
| 5993844 | Abraham et al. | Nov 1999 | A |
| 5994325 | Roufa et al. | Nov 1999 | A |
| 5997895 | Narotam et al. | Dec 1999 | A |
| 6001895 | Harvey et al. | Dec 1999 | A |
| 6008292 | Lee et al. | Dec 1999 | A |
| 6015844 | Harvey et al. | Jan 2000 | A |
| 6039686 | Robert | Mar 2000 | A |
| 6042534 | Gellman et al. | Mar 2000 | A |
| 6042592 | Schmitt | Mar 2000 | A |
| 6043089 | Sugiyama et al. | Mar 2000 | A |
| 6051425 | Morota et al. | Apr 2000 | A |
| 6056688 | Benderev et al. | May 2000 | A |
| 6056970 | Greenawalt et al. | May 2000 | A |
| 6057148 | Sugiyama et al. | May 2000 | A |
| 6063396 | Kelleher | May 2000 | A |
| 6066776 | Goodwin et al. | May 2000 | A |
| 6066777 | Benchetrit | May 2000 | A |
| 6071292 | Makower et al. | Jun 2000 | A |
| 6077281 | Das | Jun 2000 | A |
| 6080194 | Pachence et al. | Jun 2000 | A |
| 6083522 | Chu et al. | Jul 2000 | A |
| 6090116 | Aversa et al. | Jul 2000 | A |
| 6113623 | Sgro | Sep 2000 | A |
| 6120539 | Eldridge et al. | Sep 2000 | A |
| 6132765 | Dicosmo et al. | Oct 2000 | A |
| 6143037 | Goldstein et al. | Nov 2000 | A |
| 6153292 | Bell et al. | Nov 2000 | A |
| 6162962 | Hinsch et al. | Dec 2000 | A |
| 6165488 | Tardy et al. | Dec 2000 | A |
| 6171318 | Kugel et al. | Jan 2001 | B1 |
| 6174320 | Kugel et al. | Jan 2001 | B1 |
| 6176863 | Kugel et al. | Jan 2001 | B1 |
| 6179872 | Bell et al. | Jan 2001 | B1 |
| 6180848 | Flament et al. | Jan 2001 | B1 |
| 6197325 | Macphee et al. | Mar 2001 | B1 |
| 6197934 | Devore et al. | Mar 2001 | B1 |
| 6197935 | Doillon et al. | Mar 2001 | B1 |
| 6210439 | Firmin et al. | Apr 2001 | B1 |
| 6214020 | Mulhauser et al. | Apr 2001 | B1 |
| 6221109 | Geistlich et al. | Apr 2001 | B1 |
| 6224616 | Kugel | May 2001 | B1 |
| 6231879 | Li et al. | May 2001 | B1 |
| 6241768 | Agarwal et al. | Jun 2001 | B1 |
| 6258124 | Darois et al. | Jul 2001 | B1 |
| 6262332 | Ketharanathan | Jul 2001 | B1 |
| 6264702 | Ory et al. | Jul 2001 | B1 |
| 6267772 | Mulhauser et al. | Jul 2001 | B1 |
| 6270530 | Eldridge et al. | Aug 2001 | B1 |
| 6277397 | Shimizu | Aug 2001 | B1 |
| 6280453 | Kugel et al. | Aug 2001 | B1 |
| 6287316 | Agarwal et al. | Sep 2001 | B1 |
| 6290708 | Kugel et al. | Sep 2001 | B1 |
| 6306079 | Trabucco | Oct 2001 | B1 |
| 6306424 | Vyakamam et al. | Oct 2001 | B1 |
| 6312474 | Francis et al. | Nov 2001 | B1 |
| 6319264 | Tormala et al. | Nov 2001 | B1 |
| 6328686 | Robert | Dec 2001 | B1 |
| 6334872 | Termin et al. | Jan 2002 | B1 |
| 6383201 | Dong | May 2002 | B1 |
| 6391060 | Ory et al. | May 2002 | B1 |
| 6391333 | Li et al. | May 2002 | B1 |
| 6391939 | Tayot et al. | May 2002 | B2 |
| 6408656 | Ory et al. | Jun 2002 | B1 |
| 6410044 | Chudzik et al. | Jun 2002 | B1 |
| 6413742 | Olsen et al. | Jul 2002 | B1 |
| 6425924 | Rousseau | Jul 2002 | B1 |
| 6428978 | Olsen et al. | Aug 2002 | B1 |
| 6436030 | Rehil | Aug 2002 | B2 |
| 6440167 | Shimizu | Aug 2002 | B2 |
| 6443964 | Ory et al. | Sep 2002 | B1 |
| 6447551 | Goldmann | Sep 2002 | B1 |
| 6447802 | Sessions et al. | Sep 2002 | B2 |
| 6448378 | Devore et al. | Sep 2002 | B2 |
| 6451032 | Ory et al. | Sep 2002 | B1 |
| 6451301 | Sessions et al. | Sep 2002 | B1 |
| 6454787 | Maddalo et al. | Sep 2002 | B1 |
| 6477865 | Matsumoto | Nov 2002 | B1 |
| 6479072 | Morgan et al. | Nov 2002 | B1 |
| 6485503 | Jacobs et al. | Nov 2002 | B2 |
| 6500464 | Ceres et al. | Dec 2002 | B2 |
| 6500777 | Wiseman et al. | Dec 2002 | B1 |
| 6509031 | Miller et al. | Jan 2003 | B1 |
| 6511958 | Atkinson et al. | Jan 2003 | B1 |
| 6514286 | Leatherbury et al. | Feb 2003 | B1 |
| 6514514 | Atkinson et al. | Feb 2003 | B1 |
| 6540773 | Dong | Apr 2003 | B2 |
| 6541023 | Andre et al. | Apr 2003 | B1 |
| 6548077 | Gunasekaran | Apr 2003 | B1 |
| 6554855 | Dong | Apr 2003 | B1 |
| 6559119 | Burgess et al. | May 2003 | B1 |
| 6566345 | Miller et al. | May 2003 | B2 |
| 6575988 | Rousseau | Jun 2003 | B2 |
| 6576019 | Atala | Jun 2003 | B1 |
| 6596002 | Therin et al. | Jul 2003 | B2 |
| 6596304 | Bayon et al. | Jul 2003 | B1 |
| 6599323 | Melican et al. | Jul 2003 | B2 |
| 6599524 | Li et al. | Jul 2003 | B2 |
| 6599690 | Abraham et al. | Jul 2003 | B1 |
| 6610006 | Amid et al. | Aug 2003 | B1 |
| 6613348 | Jain | Sep 2003 | B1 |
| 6616685 | Rousseau | Sep 2003 | B2 |
| 6623963 | Mueller et al. | Sep 2003 | B1 |
| 6630414 | Matsumoto | Oct 2003 | B1 |
| 6637437 | Hungerford et al. | Oct 2003 | B1 |
| 6638284 | Rousseau et al. | Oct 2003 | B1 |
| 6645226 | Jacobs et al. | Nov 2003 | B1 |
| 6652594 | Francis et al. | Nov 2003 | B2 |
| 6652595 | Nicolo | Nov 2003 | B1 |
| 6653450 | Berg et al. | Nov 2003 | B1 |
| 6656206 | Corcoran et al. | Dec 2003 | B2 |
| 6660280 | Allard et al. | Dec 2003 | B1 |
| 6669735 | Pelissier | Dec 2003 | B1 |
| 6670018 | Fujita et al. | Dec 2003 | B2 |
| 6682760 | Noff et al. | Jan 2004 | B2 |
| 6685714 | Rousseau | Feb 2004 | B2 |
| 6699287 | Son et al. | Mar 2004 | B2 |
| 6706684 | Bayon et al. | Mar 2004 | B1 |
| 6706690 | Reich et al. | Mar 2004 | B2 |
| 6712859 | Rousseau et al. | Mar 2004 | B2 |
| 6719795 | Bryan et al. | Apr 2004 | B1 |
| 6723335 | Moehlenbruck et al. | Apr 2004 | B1 |
| 6726660 | Hessel et al. | Apr 2004 | B2 |
| 6730299 | Tayot et al. | May 2004 | B1 |
| 6736823 | Darois et al. | May 2004 | B2 |
| 6736854 | Vadurro et al. | May 2004 | B2 |
| 6737371 | Planck et al. | May 2004 | B1 |
| 6743435 | Devore et al. | Jun 2004 | B2 |
| 6746458 | Cloud | Jun 2004 | B1 |
| 6752834 | Geistlich et al. | Jun 2004 | B2 |
| 6755868 | Rousseau | Jun 2004 | B2 |
| 6773723 | Spiro et al. | Aug 2004 | B1 |
| 6783554 | Amara et al. | Aug 2004 | B2 |
| 6790213 | Cherok et al. | Sep 2004 | B2 |
| 6790454 | Abdul et al. | Sep 2004 | B1 |
| 6800082 | Rousseau | Oct 2004 | B2 |
| 6833408 | Sehl et al. | Dec 2004 | B2 |
| 6835336 | Watt | Dec 2004 | B2 |
| 6852330 | Bowman et al. | Feb 2005 | B2 |
| 6869938 | Schwartz et al. | Mar 2005 | B1 |
| 6872227 | Sump et al. | Mar 2005 | B2 |
| 6893653 | Abraham et al. | May 2005 | B2 |
| 6896904 | Spiro et al. | May 2005 | B2 |
| 6926723 | Mulhauser et al. | Aug 2005 | B1 |
| 6936276 | Spiro et al. | Aug 2005 | B2 |
| 6939562 | Spiro et al. | Sep 2005 | B2 |
| 6949625 | Tayot | Sep 2005 | B2 |
| 6966918 | Schuldt-Hempe et al. | Nov 2005 | B1 |
| 6971252 | Therin et al. | Dec 2005 | B2 |
| 6974679 | Andre et al. | Dec 2005 | B2 |
| 6974862 | Ringeisen et al. | Dec 2005 | B2 |
| 6977231 | Matsuda | Dec 2005 | B1 |
| 6984392 | Bechert et al. | Jan 2006 | B2 |
| 6988386 | Okawa et al. | Jan 2006 | B1 |
| 7011688 | Gryska et al. | Mar 2006 | B2 |
| 7021086 | Ory et al. | Apr 2006 | B2 |
| 7022358 | Eckmayer et al. | Apr 2006 | B2 |
| 7025063 | Snitkin et al. | Apr 2006 | B2 |
| 7041868 | Greene et al. | May 2006 | B2 |
| 7060103 | Carr et al. | Jun 2006 | B2 |
| RE39172 | Bayon et al. | Jul 2006 | E |
| 7070558 | Gellman et al. | Jul 2006 | B2 |
| 7087065 | Ulmsten et al. | Aug 2006 | B2 |
| 7094261 | Zotti et al. | Aug 2006 | B2 |
| 7098315 | Schaufler | Aug 2006 | B2 |
| 7101381 | Ford et al. | Sep 2006 | B2 |
| 7115220 | Dubson et al. | Oct 2006 | B2 |
| 7156804 | Nicolo | Jan 2007 | B2 |
| 7156858 | Schuldt-Hempe et al. | Jan 2007 | B2 |
| 7175852 | Simmoteit et al. | Feb 2007 | B2 |
| 7192604 | Brown et al. | Mar 2007 | B2 |
| 7207962 | Anand et al. | Apr 2007 | B2 |
| 7214765 | Ringeisen et al. | May 2007 | B2 |
| 7226611 | Yura et al. | Jun 2007 | B2 |
| 7229453 | Anderson et al. | Jun 2007 | B2 |
| 7252837 | Guo et al. | Aug 2007 | B2 |
| 7279177 | Looney et al. | Oct 2007 | B2 |
| 7331199 | Ory et al. | Feb 2008 | B2 |
| 7393319 | Merade et al. | Jul 2008 | B2 |
| 7556598 | Rao | Jul 2009 | B2 |
| 7594921 | Browning | Sep 2009 | B2 |
| 7614258 | Cherok et al. | Nov 2009 | B2 |
| 7615065 | Priewe et al. | Nov 2009 | B2 |
| 7662169 | Wittmann | Feb 2010 | B2 |
| 7670380 | Cauthen, III et al. | Mar 2010 | B2 |
| 7682381 | Rakos et al. | Mar 2010 | B2 |
| 7709017 | Tayot et al. | May 2010 | B2 |
| 7718556 | Matsuda et al. | May 2010 | B2 |
| 7732354 | Fricke et al. | Jun 2010 | B2 |
| 7785334 | Ford et al. | Aug 2010 | B2 |
| 7789888 | Bartee et al. | Sep 2010 | B2 |
| 7799767 | Lamberti et al. | Sep 2010 | B2 |
| 7806905 | Ford et al. | Oct 2010 | B2 |
| 7824420 | Eldridge et al. | Nov 2010 | B2 |
| 7828854 | Rousseau et al. | Nov 2010 | B2 |
| 7900484 | Cherok et al. | Mar 2011 | B2 |
| 7931695 | Ringeisen | Apr 2011 | B2 |
| 8052759 | Dupic et al. | Nov 2011 | B2 |
| 8079023 | Chen | Dec 2011 | B2 |
| 8100924 | Browning | Jan 2012 | B2 |
| 8123817 | Intoccia et al. | Feb 2012 | B2 |
| 8142515 | Therin et al. | Mar 2012 | B2 |
| 8157821 | Browning | Apr 2012 | B2 |
| 8157822 | Browning | Apr 2012 | B2 |
| 8182545 | Cherok et al. | May 2012 | B2 |
| 8197837 | Jamiolkowski et al. | Jun 2012 | B2 |
| 8206632 | Rousseau et al. | Jun 2012 | B2 |
| 8215310 | Browning | Jul 2012 | B2 |
| 8317872 | Adams | Nov 2012 | B2 |
| 8323675 | Greenawalt | Dec 2012 | B2 |
| 8343232 | Adzich et al. | Jan 2013 | B2 |
| 8366787 | Brown et al. | Feb 2013 | B2 |
| 8435307 | Paul | May 2013 | B2 |
| 8470355 | Skalla et al. | Jun 2013 | B2 |
| 8562633 | Cully et al. | Oct 2013 | B2 |
| 8574627 | Martakos et al. | Nov 2013 | B2 |
| 8709094 | Stad et al. | Apr 2014 | B2 |
| 8734471 | Deitch | May 2014 | B2 |
| 8753360 | Gleiman et al. | Jun 2014 | B2 |
| 8758800 | Stopek et al. | Jun 2014 | B2 |
| 8784294 | Goddard | Jul 2014 | B2 |
| 8814887 | Walther et al. | Aug 2014 | B2 |
| 8828092 | Toso et al. | Sep 2014 | B2 |
| 8834864 | Odar et al. | Sep 2014 | B2 |
| 8846060 | Archibald et al. | Sep 2014 | B2 |
| 8865215 | Ladet et al. | Oct 2014 | B2 |
| 8877233 | Obermiller et al. | Nov 2014 | B2 |
| 8911504 | Mathisen et al. | Dec 2014 | B2 |
| 8920370 | Sholev et al. | Dec 2014 | B2 |
| 8956373 | Ford et al. | Feb 2015 | B2 |
| 8962006 | Bayon et al. | Feb 2015 | B2 |
| 8968762 | Ladet et al. | Mar 2015 | B2 |
| 8979935 | Lozier et al. | Mar 2015 | B2 |
| 9034357 | Stopek | May 2015 | B2 |
| 9113993 | Lee | Aug 2015 | B2 |
| 9211175 | Stopek et al. | Dec 2015 | B2 |
| 9216075 | Bailly et al. | Dec 2015 | B2 |
| 20020087174 | Capello | Jul 2002 | A1 |
| 20020095218 | Carr et al. | Jul 2002 | A1 |
| 20030086975 | Ringeisen | May 2003 | A1 |
| 20030114937 | Leatherbury et al. | Jun 2003 | A1 |
| 20030133967 | Ruszczak et al. | Jul 2003 | A1 |
| 20030225355 | Butler | Dec 2003 | A1 |
| 20040034373 | Schuldt-Hempe et al. | Feb 2004 | A1 |
| 20040054376 | Ory et al. | Mar 2004 | A1 |
| 20040059356 | Gingras | Mar 2004 | A1 |
| 20040101546 | Gorman et al. | May 2004 | A1 |
| 20050002893 | Goldmann | Jan 2005 | A1 |
| 20050021058 | Negro | Jan 2005 | A1 |
| 20050085924 | Darois et al. | Apr 2005 | A1 |
| 20050113849 | Popadiuk et al. | May 2005 | A1 |
| 20050137512 | Campbell et al. | Jun 2005 | A1 |
| 20050142161 | Freeman et al. | Jun 2005 | A1 |
| 20050148963 | Brennan | Jul 2005 | A1 |
| 20050175659 | Macomber et al. | Aug 2005 | A1 |
| 20050191356 | Pahmeier | Sep 2005 | A1 |
| 20050232979 | Shoshan | Oct 2005 | A1 |
| 20050267521 | Forsberg | Dec 2005 | A1 |
| 20050288691 | Leiboff | Dec 2005 | A1 |
| 20060116696 | Odermatt et al. | Jun 2006 | A1 |
| 20060135921 | Wiercinski et al. | Jun 2006 | A1 |
| 20060147501 | Hillas et al. | Jul 2006 | A1 |
| 20060216320 | Kitazono et al. | Sep 2006 | A1 |
| 20060252981 | Matsuda et al. | Nov 2006 | A1 |
| 20060253203 | Alvarado | Nov 2006 | A1 |
| 20060282103 | Fricke et al. | Dec 2006 | A1 |
| 20070088391 | Mcalexander et al. | Apr 2007 | A1 |
| 20070129736 | Solecki | Jun 2007 | A1 |
| 20070198040 | Buevich et al. | Aug 2007 | A1 |
| 20070299538 | Roeber | Dec 2007 | A1 |
| 20080091276 | Deusch et al. | Apr 2008 | A1 |
| 20080109017 | Herweck et al. | May 2008 | A1 |
| 20080113001 | Herweck et al. | May 2008 | A1 |
| 20080172071 | Barker | Jul 2008 | A1 |
| 20080255593 | St-Germain | Oct 2008 | A1 |
| 20090035341 | Wagener et al. | Feb 2009 | A1 |
| 20090036996 | Roeber | Feb 2009 | A1 |
| 20090068250 | Gravagna et al. | Mar 2009 | A1 |
| 20090105526 | Piroli et al. | Apr 2009 | A1 |
| 20090163936 | Yang et al. | Jun 2009 | A1 |
| 20090187197 | Roeber et al. | Jul 2009 | A1 |
| 20090192530 | Adzich et al. | Jul 2009 | A1 |
| 20090204129 | Fronio | Aug 2009 | A1 |
| 20090216338 | Gingras et al. | Aug 2009 | A1 |
| 20090270999 | Brown | Oct 2009 | A1 |
| 20090281558 | Li | Nov 2009 | A1 |
| 20090318752 | Evans et al. | Dec 2009 | A1 |
| 20100016872 | Bayon | Jan 2010 | A1 |
| 20100104608 | Abuzaina et al. | Apr 2010 | A1 |
| 20100318108 | Datta et al. | Dec 2010 | A1 |
| 20110015760 | Kullas | Jan 2011 | A1 |
| 20110081677 | Luo et al. | Apr 2011 | A1 |
| 20110144667 | Horton et al. | Jun 2011 | A1 |
| 20110190795 | Hotter et al. | Aug 2011 | A1 |
| 20110238094 | Thomas et al. | Sep 2011 | A1 |
| 20110251699 | Ladet | Oct 2011 | A1 |
| 20110257666 | Ladet et al. | Oct 2011 | A1 |
| 20110311632 | Roorda et al. | Dec 2011 | A1 |
| 20120016388 | Houard et al. | Jan 2012 | A1 |
| 20120029537 | Mortarino | Feb 2012 | A1 |
| 20120065727 | Reneker et al. | Mar 2012 | A1 |
| 20120082712 | Stopek et al. | Apr 2012 | A1 |
| 20120116425 | Intoccia et al. | May 2012 | A1 |
| 20120150204 | Mortarino et al. | Jun 2012 | A1 |
| 20120165937 | Montanari et al. | Jun 2012 | A1 |
| 20120179175 | Hammell et al. | Jul 2012 | A1 |
| 20120179176 | Wilson et al. | Jul 2012 | A1 |
| 20120197415 | Montanari et al. | Aug 2012 | A1 |
| 20140044861 | Boey et al. | Feb 2014 | A1 |
| 20140364684 | Lecuivre et al. | Dec 2014 | A1 |
| 20170189574 | Jaillon et al. | Jul 2017 | A1 |
| 20170290956 | Vestberg et al. | Oct 2017 | A1 |
| Number | Date | Country |
|---|---|---|
| 1317836 | May 1993 | CA |
| 201879864 | Jun 2011 | CN |
| 19544162 | Apr 1997 | DE |
| 19718903 | Dec 1997 | DE |
| 19751733 | Dec 1998 | DE |
| 19832634 | Jan 2000 | DE |
| 10019604 | Oct 2001 | DE |
| 10120942 | Oct 2001 | DE |
| 10043396 | Jun 2002 | DE |
| 0194192 | Sep 1986 | EP |
| 0248544 | Dec 1987 | EP |
| 0263360 | Apr 1988 | EP |
| 0276890 | Aug 1988 | EP |
| 0372969 | Jun 1990 | EP |
| 0531742 | Mar 1993 | EP |
| 0544485 | Jun 1993 | EP |
| 0552576 | Jul 1993 | EP |
| 0611561 | Aug 1994 | EP |
| 0614650 | Sep 1994 | EP |
| 0621014 | Oct 1994 | EP |
| 0625891 | Nov 1994 | EP |
| 0637452 | Feb 1995 | EP |
| 0664132 | Jul 1995 | EP |
| 0705878 | Apr 1996 | EP |
| 0719527 | Jul 1996 | EP |
| 0774240 | May 1997 | EP |
| 0797962 | Oct 1997 | EP |
| 0800791 | Oct 1997 | EP |
| 0827724 | Mar 1998 | EP |
| 0836838 | Apr 1998 | EP |
| 0847727 | Jun 1998 | EP |
| 0876808 | Nov 1998 | EP |
| 0895762 | Feb 1999 | EP |
| 0898944 | Mar 1999 | EP |
| 1017415 | Jul 2000 | EP |
| 1036545 | Sep 2000 | EP |
| 1052319 | Nov 2000 | EP |
| 1055757 | Nov 2000 | EP |
| 1090590 | Apr 2001 | EP |
| 1216717 | Jun 2002 | EP |
| 1216718 | Jun 2002 | EP |
| 0693523 | Nov 2002 | EP |
| 1315468 | Jun 2003 | EP |
| 1382728 | Jan 2004 | EP |
| 1484070 | Dec 2004 | EP |
| 1561480 | Aug 2005 | EP |
| 1645232 | Apr 2006 | EP |
| 1674048 | Jun 2006 | EP |
| 1691606 | Aug 2006 | EP |
| 1782848 | May 2007 | EP |
| 2229918 | Sep 2010 | EP |
| 2522376 | Nov 2012 | EP |
| 2244853 | Apr 1975 | FR |
| 2257262 | Aug 1975 | FR |
| 2308349 | Nov 1976 | FR |
| 2453231 | Oct 1980 | FR |
| 2612392 | Sep 1988 | FR |
| 2715309 | Jul 1995 | FR |
| 2715405 | Jul 1995 | FR |
| 2724563 | Mar 1996 | FR |
| 2730406 | Aug 1996 | FR |
| 2744906 | Aug 1997 | FR |
| 2766698 | Feb 1999 | FR |
| 2771622 | Jun 1999 | FR |
| 2773057 | Jul 1999 | FR |
| 2774277 | Aug 1999 | FR |
| 2779937 | Dec 1999 | FR |
| 2859624 | Mar 2005 | FR |
| 2863277 | Jun 2005 | FR |
| 2876020 | Apr 2006 | FR |
| 2884706 | Oct 2006 | FR |
| 2929834 | Oct 2009 | FR |
| 2953709 | Jun 2011 | FR |
| 1174814 | Dec 1969 | GB |
| 2051153 | Jan 1981 | GB |
| 2306110 | Apr 1997 | GB |
| H0332677 | Feb 1991 | JP |
| H05237128 | Sep 1993 | JP |
| H09137380 | May 1997 | JP |
| H11146888 | Jun 1999 | JP |
| 2008538300 | Oct 2008 | JP |
| 2011078767 | Apr 2011 | JP |
| 8902445 | Mar 1989 | WO |
| 8908467 | Sep 1989 | WO |
| 9009769 | Sep 1990 | WO |
| 9012551 | Nov 1990 | WO |
| 9206639 | Apr 1992 | WO |
| 9220349 | Nov 1992 | WO |
| 9310731 | Jun 1993 | WO |
| 9311805 | Jun 1993 | WO |
| 9318174 | Sep 1993 | WO |
| 9417747 | Aug 1994 | WO |
| 9507666 | Mar 1995 | WO |
| 9518638 | Jul 1995 | WO |
| 9532687 | Dec 1995 | WO |
| 9603091 | Feb 1996 | WO |
| 9608277 | Mar 1996 | WO |
| 9609795 | Apr 1996 | WO |
| 9614805 | May 1996 | WO |
| 9641588 | Dec 1996 | WO |
| 9735533 | Oct 1997 | WO |
| 9835632 | Aug 1998 | WO |
| 9849967 | Nov 1998 | WO |
| 9905990 | Feb 1999 | WO |
| 9906079 | Feb 1999 | WO |
| 9906080 | Feb 1999 | WO |
| 9951163 | Oct 1999 | WO |
| 0016821 | Mar 2000 | WO |
| 0067663 | Nov 2000 | WO |
| 0115625 | Mar 2001 | WO |
| 0180773 | Nov 2001 | WO |
| 0181667 | Nov 2001 | WO |
| 0207648 | Jan 2002 | WO |
| 0217853 | Mar 2002 | WO |
| 02078568 | Oct 2002 | WO |
| 03002168 | Jan 2003 | WO |
| 2004004600 | Jan 2004 | WO |
| 2004071349 | Aug 2004 | WO |
| 2004078120 | Sep 2004 | WO |
| 2004103212 | Dec 2004 | WO |
| 2005011280 | Feb 2005 | WO |
| 2005013863 | Feb 2005 | WO |
| 2005018698 | Mar 2005 | WO |
| 2005048708 | Jun 2005 | WO |
| 2005105172 | Nov 2005 | WO |
| 2006018552 | Feb 2006 | WO |
| 2006023444 | Mar 2006 | WO |
| 2007042281 | Apr 2007 | WO |
| 2007048099 | Apr 2007 | WO |
| 2009031035 | Mar 2009 | WO |
| 2009031047 | Mar 2009 | WO |
| 2009071998 | Jun 2009 | WO |
| 2009156866 | Dec 2009 | WO |
| 2010043978 | Apr 2010 | WO |
| 2011007062 | Jan 2011 | WO |
| 2011026987 | Mar 2011 | WO |
| 2011038740 | Apr 2011 | WO |
| 2014020132 | Feb 2014 | WO |
| Entry |
|---|
| Adeline Martin et al: Build-up of an antimicrobial multilayer coating on a textile support based on a methylene blue-poly (cyclodextrin) com11 , Biomedical Materials, Institute of Physics Publishing, Bristol, GB, vol. 8, No. 6, Nov. 26, 2013 (Nov. 26, 2013), p. 65006. |
| Aiping Z et al: “Blood compatibility of surface-engineered poly(ethylene terephthalate) via o-carboxymethylchitosan”, Colloids and Surfaces. B, Biointerfaces, Elsevier, Amsterdam, NL, vol. 50, No. 2, Jul. 1, 2006 (Jul. 1, 2006), pp. 120-125. |
| Amid, P., “Lichtenstein tension-free hernioplasty: Its inception, evolution, and principles,” Hernia, 2004; pp. 1-7, 8, published online Sep. 2003. |
| Andrea S. Gobin et al: Repair and Regeneration of the Abdominal Wall Musculofascial Defect Using Silk Fibroin-Chitosan Blend11 , Tissue Engineering, vol. 12, No. 0, Jan. 1, 2006 (Jan. 1, 2006), p. 3383. |
| Blondin, C. et al., “Inhibition of Complement Activation by Natural Sulfated Polysaccharides (Fucans) from Brown Seaweed,” Molecular Immuol., Mar. 1994, pp. 247-253, 31(4). |
| Blondin, C. et al., “Relationships between chemical characteristics and anticomplementary activity of fucans,” Biomaterials, Mar. 1996, pp. 597-603, 17(6). |
| Boisson-Vidal, C. et al., “Neoangiogenesis Induced by Progenitor Endothelial Cells: Effect of Fucoidan From Marine Algae,” Cardiovascular & Hematological Agents in Medicinal Chem., Jan. 2007, pp. 67-77, 5(1). |
| Bracco, P. et al., “Comparison of polypropylene and polyethylene terephthalate (Dacron) meshes for abdominal wall hernia repair: A chemical and morphological study,” Hernia, 2005, pp. 51-55, 9 (1), published online Sep. 2004. |
| Collins, R. et al., “Use of collagen film as a dural substitute: Preliminary animal studies,” Journal of Biomedical Materials Research, Feb. 1991, pp. 267-276, vol. 25. |
| Doillon, C.J., et al., “Collagen-based wound dressings: Control of the pore structure and morphology,” J. Biomed. Mater. Res., Oct. 1986, pp. 1219-1228, vol. 20(8). |
| Ellouali, M. et al., “Antitumor Activity of Low Molecular Weight Fucans Extracted from Brown Seaweed Ascophyllum nodosum,” Anticancer Res., Nov.-Dec. 1993, pp. 2011-2020, 12 (6A). |
| Fu J et al: Construction of anti-adhesive and antibacterial multilayer films via layer-by-layer assembly of heparin and chitosan11 , Biomaterials, Elsevier Science Publishers BV., Barking, GB, vol. 26, No. 33, Nov. 1, 2005 (Nov. 1, 2005), pp. 6684-6692). |
| Haneji, K. et al., “Fucoidan extracted from Cladosiphon Okamuranus Tokida Induces Apoptosis of Human T-cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells,” Nutrition and Cancer, 2005, pp. 189-201, 52(2), published online Nov. 2009. |
| Haroun-Bouhedja, F. et al., “In Vitro Effects of Fucans on MDA-MB231 Tumor Cell Adhesion and Invasion,” Anticancer Res., Jul.-Aug. 2002, pp. 2285-2292, 22(4). |
| Haroun-Bouhedja, F. et al., “Relationship between sulfate groups and biological activities of fucans,” Thrombosis Res., Dec. 2000, pp. 453-459, 100(5). |
| Hirano, S. et al., “The blood biocompatibility of chitosan and N-acylchitosans,” J. Biomed. Mater. Res., Apr. 1985, 413-417, 19. |
| Hong Li et al: Layer-by-layer hyaluronic acid-chitosan coating promoted new collagen ingrowth into a poly(ethylene terephthalate) artificial ligament in a rabbit medical collateral ligament (MCL) reconstruction model11 , Journal of Biomaterials Science, Polymer Edition, vol. 24, No. 4, Mar. 1, 2013 (Mar. 1, 2013), pp. 431-446. |
| Junge, K. et al., “Functional and Morphologic Properties of a Modified Mesh for Inguinal Hernia Repair,” World J. Burg., Sep. 2002, pp. 1472-1480, 26. |
| Kanabar, V. et al., “Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle,” Br. J. Pharmacol., Oct. 2005, pp. 370-777, 146(3). |
| Klinge, U. et al., “Foreign Body Reaction to Meshes Used for the Repair of Abdominal Wall Hernias,” Eur J. Surg, Sep. 1999, pp. 665-673, 165. |
| Klinge, U. et al., “Functional and Morphological Evaluation of a Low-Weight, Monofilament Polypropylene Mesh for Hernia Repair,” J. Biomed. Mater. Res., Jan. 2002, pp. 129-136, 63. |
| Lamarque, G. et al, “New Route of Deacetylation of alpha- and beta-Chitins by Means of Freeze-Pump Out-Thaw cycles” Biomacromolecules, May-Jun. 2005, pp. 1380-1388, 6. |
| Lamarque, G. et al., “Comparative Study of the First Heterogeneous Deacetylation of alpha- and beta-Chitins in a Multistep Process” Biomacromolecules May-Jun. 2004, 992-1001, 5. |
| Lamarque, G. et al., “Comparative Study of the Second and Third Heterogeneous Deacetylations of alpha- and beta-Chitins in a Multistep Process” Biomacromolecules, Sep.-Oct. 5, 2004, pp. 1899-1907, 5. |
| Langenbech, M. R. et al., “Comparison of biomaterials in the early postoperative period,” Surg Enclose., May 2003, pp. 1105-1109, 17 (7). |
| LD Wright et al: PDLA/PLLA and PDLA/PCL nanofibers with a chitosan-based hydrogel in composite scaffolds for tissue engineered cartilage11 , Journal of Tissue Engineering and Regenerative Medicine, vol. 8, No. 12, Dec. 1, 2014 (Dec. 1, 2014), pp. 946-954. |
| Liu et al: “Surface modification of poly(ethylene terephthalate) via hydrolysis and layer-by-layer assembly of chitosan and chondroitin sulfate to construct cytocompatible layer for human endothelial cells”, Colloids and Surfaces. Biointerfaces, Elsevier, Amsterdam, NL, vol. 46, No. 2, Dec. 10, 2005 (Dec. 10, 2005), pp. 117-126. |
| Logeart, D. et al., “Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle Cell proliferation. II. Degradation and molecular weight effect,” Eur. J. Cell. Biol., Dec. 1997, pp. 385-390, 74(4). |
| Malette, W. G. et al., “Chitosan, A New Hemostatic,” Ann Th. Surg., Jul. 1983, pp. 55-58, 36. |
| Muzzarelli, R. et al., “Reconstruction of parodontal tissue with chitosan,” Biomaterials, Nov. 1989, pp. 598-604, 10. |
| O'Brien, F. J. et al., “Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds” Biomaterials, Mar. 2004, pp. 1077-1086, vol. 25, Issue 6. |
| O'Dwyer, P. et al., “Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair,” Br. J. Surg., Feb. 2005, pp. 166-170, 92(2). |
| Preliminary Search Report from French Patent Office dated Dec. 20, 2006, 3 pages. |
| Prokop, A. et al., “Water Soluble Polymers for Immunoisolation I: Complex Coacevation and Cytotoxicity,” Advances in Polymer Science, Jul. 1998, pp. 1-51, 136. |
| Rao, B. et al., “Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential,” J. Biomed. Mater. Res., Jan. 1997, pp. 21-28, 34. |
| Rosen, M. et al., “Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal,” Hernia, 2007, pp. 435-440, 11, published online Jul. 2007. |
| Sarasam A et al, Characterization of chitosan-polycaprolactone blends for tissue engineering applications11 , Biomaterials, Elsevier Science Publishers BV., Barking, GB, vol. 26, No. 27, Sep. 1, 2005 (Sep. 1, 2005), pp. 5500-5508. |
| Scheidbach, H. et al., “In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty: An experimental study in pigs,” Surg. Endosc., Feb. 2004, pp. 211-220,18(2). |
| Schoof, H. et al., Control of Pore Structure and Size in Freeze-Dried Collagen Sponges, Journal of Biomedical Materials Research, May 2001, pp. 352-357, vol. 58, No. 4. |
| Strand, S. et al., “Screening of Chitosans and Conditions for Bacterial Flocculation,” Biomacromolecules, Mar. 2001, 126-133, 2. |
| Tea Indest et al: Adsorption of Fucoidan and Chitosan Sulfate on Chitosan Modified PET Films Monitored by QCM-D11, Biomacromolecules, vol. 10, No. 3, Mar. 9, 2009 (Mar. 9, 2009), pp. 630-637. |
| Tolaimate, A., et al. “Contribution to the preparation of chitins and chitosans with controlled physico-chemical properties.” Polymer, Dec. 2003, pp. 7939-7952, 44 (26). |
| Varum, K. et al., “In vitro degradation rates of partially N-acetylated chitosans in human serum,” Carbohydrate Research, Mar. 1997, pp. 99-101, 299. |
| Welty, G. et al., “Functional impairment and complaints following incisional hernia repair with different polypropylene meshes,” Hernia, Aug. 2001; pp. 142-147, 5. |
| Zvyagintseva, T. et al., “Inhibition of complement activation by water-soluble polysaccharides of some far-eastern brown seaweeds,” Comparative Biochem and Physiol, Jul. 2000, pp. 209-215,126(3). |
| Number | Date | Country | |
|---|---|---|---|
| 20190144618 A1 | May 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15003975 | Jan 2016 | US |
| Child | 16243359 | US |
